Showing 1521-1530 of 3086 results for "".
Melanoma Treatment Landscape Evolves
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-treatment-landscape-evolves/21314/The first agent to target the PD-1 pathway, pembrolizumab may prolong life expectancy in some patients.Analyzing Risk Factors for Subsequent Primary Melanomas
https://practicaldermatology.com/topics/skin-cancer-photoprotection/analyzing-risk-factors-for-subsequent-primary-melanomas/21429/Charging Toward Stage 2 of Meaningful Use
https://practicaldermatology.com/topics/practice-management/charging-toward-stage-2-of-meaningful-use/21467/As the next stage of the Federal EHR incentive program is set to begin, the forecast remains uncertain.SPF Recommendations: Should They Change?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/spf-recommendations-should-they-change/21475/What is the minimum SPF dermatologists should be recommending to their patients?Protect Yourself Against System Breaches and Errors
https://practicaldermatology.com/topics/practice-management/protect-yourself-against-system-breaches-and-errors/21579/New reports of cyber-terrorism highlight the importance of EHR security.New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21633/Event Marketing: Strategies to Spotlight Your Practice and Cosmetic Services
https://practicaldermatology.com/topics/practice-management/event-marketing-strategies-to-spotlight-your-practice-and-cosmetic-services/20335/The notion of hosting an event can be overwhelming, but many practices find the endeavor worthwhile. Ahead are tips for success—and a word of caution.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20371/New in My Practice: OTC Skincare/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-otc-skincarenew-products/23704/The Role for Rinvoq in AD Care
https://practicaldermatology.com/topics/atopic-dermatitis/the-role-for-rinvoq-in-ad-care/23663/One of the first oral JAK inhibitors approved in dermatology expands options for moderate to severe AD.